Funding Announcements

"In normal times, we spend a lot of time travelling round the country to see clients, but when this no longer became possible due to the pandemic, we’ve had the time to review our strategic development needs and focus on where we want the business to go."

"Over the last few years our business has transformed with significant growth and we have been looking for the right partner to work with as we progress our ambitions further. The team at KCP were passionate about our business from the start and shared my vision for the future. We are delighted to welcome KCP into our business and look forward to working with the team as we continue this exciting journey."

"In funding the next stage of our growth we’ve found a partner with a depth of experience and connections across the industries we’re working in. We’ve access to Par Equity’s network and direct recent industry and technology knowledge. Their support will help ensure that we are able to build on our existing momentum to rapidly grow a successful business."

"Genomic medicine is revolutionising healthcare, transforming outcomes for patients by providing clinicians with fast, accurate and early diagnoses and the information needed to provide life-changing answers for their patients, improving wellbeing and disease management. This new funding will allow us to build on our established foundation in rare disease and bring the power of our platform to new indications and new markets. We welcome our new investors to Congenica and are grateful to our existing investors for their continued support."

"Over the last few years, we have seen a growth in both collective redress and litigation funding. Innovation by lawyers in these areas has so far been hampered by the technology available to administer them."